Search
for
Did you mean Janus Kinase?
Sort by
Research 30 of 1000+
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Inhibiting Janus kinases to treat alopecia areata
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Janus Kinase inhibitors in dermatology: a review
- The role of janus kinases in the treatment of autoimmune skin diseases
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Janus kinase inhibitors for alopecia areata: A narrative review
- The Role of Janus Kinase Inhibitors in Dermatology
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Janus kinase inhibitors in dermatology: A systematic review
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature